DOP62 Immunogenicity to second anti-TNF therapy (IMSAT): Implications for sequencing of biologic therapy (2021)

First Author: Chanchlani N

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ecco-jcc/jjab073.101

Publication URI: http://dx.doi.org/10.1093/ecco-jcc/jjab073.101

Type: Journal Article/Review

Parent Publication: Journal of Crohn's and Colitis

Issue: Supplement_1